Ronald Fogel
Gastroenterology · Chesterfield, MINPI 1588641633
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 29.0% of the total. Reporting peaked in 2019 at $4,110 and has fallen 88.3% since, to $482 in 2025.
Across 205 payments — averaging $56.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Gilead$3K
- Merck$2K
- E.r. Squibb & Sons, L.L.C.$2K
- Johnson & Johnson$481
- AbbVie$399
- plus $1K from 16 others
Across 1,965 payments — averaging $2785.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$890K
- AbbVie$868K
- Takeda Pharmaceuticals U.S.A., Inc.$615K
- Eli Lilly$471K
- Gilead$439K
- Janssen Research & Development, LLC$435K
- plus $1.8M from 17 others
What the payments were for
- Consulting fees$6,87060%
- Travel & lodging$1,38612%
- Food & beverage$3,09127%
- Education$1431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $3,333 |
| Gilead | 24 | $2,797 |
| Merck | 13 | $1,674 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,500 |
| Johnson & Johnson | 26 | $481 |
| AbbVie(2 entities) | 24 | $399 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $299 |
| QOL Medical, LLC | 19 | $287 |
| Nestle Healthcare Nutrition Inc. | 11 | $178 |
| Pfizer | 13 | $93 |
| Aimmune Therapeutics, Inc. | 5 | $77 |
| Eli Lilly | 2 | $56 |
| Ardelyx, Inc. | 3 | $52 |
| Braintree Laboratories, Inc. | 4 | $51 |
| Madrigal Pharmaceuticals | 2 | $47 |
| UCB, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Evoke Pharma, Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORENCIA$1,500
How this compares
$11,490 in reported general payments places this provider in the 85th percentile of 497 gastroenterology providers in Michigan.
Other gastroenterology in Chesterfield
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
- Bradford WhitmerSaint Clair Shores$206K
- Mohammed BarawiSt Clair Shores$193K
- Stuart GordonDetroit$178K
- Mohamad AlsibaeRoyal Oak$127K
- Allison SchulmanAnn Arbor$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.